• Some Patients with Hydralazine-related AAV Develop Advanced Kidney Disease, Study Finds
  • Treatment for Severe Acne May in Rare Cases Cause AAV, Patient Study Shows
  • Low Immune Protein Levels Predict Worse ANCA-associated Vasculitis Survival, Study Finds
  • Avacopan Safer, More Effective than Standard Therapy in AAV Patients, Phase 2 Trials Show
  • Azathioprine Therapy in AAV Patients Not Affected by TPMT Enzyme Activity, Study Shows
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Faulty Immune System Component in AAV Leads to Neutrophil Activation, Kidney Damage, Study Shows
  • Study Links White Blood Cell Precursors to Vasculitis Severity at Diagnosis
  • FDA Approves AESKU’s Automated Diagnostic Tests for ANCA-associated Vasculitis
  • Rare Mutations in ATT Protein May Lead to Development of AAV, Case Report Suggests
  • AAV Patients Have Greater Risk for Cardiovascular Disease, Venous Thromboembolism, Study Finds
  • Rituxan Can in Rare Cases Lead to Very Low Platelet Levels in ANCA Vasculitis Patients, Study Says